Kathryn E. Wengel - Jun 12, 2023 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Chief TO and Risk Officer
Signature
/s/ Laura McFalls, as attorney-in-fact for Kathryn E. Wengel
Stock symbol
JNJ
Transactions as of
Jun 12, 2023
Transactions value $
-$1,994,400
Form type
4
Date filed
6/14/2023, 04:19 PM
Previous filing
Feb 15, 2023
Next filing
Feb 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Sale -$1.99M -12.5K -15.9% $160.00 65.9K Jun 12, 2023 Direct
holding JNJ Common Stock 59 Jun 12, 2023 By 401k F1
holding JNJ Common Stock 281 Jun 12, 2023 By ESOP F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/30/2023).
F2 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/30/2023).